She is a clinical scientist who holds a Ph.D. in Cell Therapy from University College of London.

She studied CAR T cells and the immune landscape of Multiple Myeloma patients, and made fundamental contributions to the current understanding of the immune microenvironment and the underlying activity of CAR T cell therapy; she was awarded a Ph.D. in 2020.

She then went on to receive training in CAR T cell manufacturing in Germany, followed by American Board Certification in Regenerative Medicine.

She is now managing the CAR T in-house manufacturing project at King Faisal Hospital, Riyadh, Saudi Arabia.